Company Filing History:
1 out of 263 
1 out of 126 
Years Active: 2023
Title: Dhanesh Amarnani: Innovator in Ocular Research
Introduction
Dhanesh Amarnani is a notable inventor based in Allston, MA (US). He has made significant contributions to the field of ocular research, particularly in the treatment of proliferative vitreoretinopathy. His innovative work focuses on the inhibition of RUNX1, which plays a crucial role in various ocular conditions.
Latest Patents
Dhanesh Amarnani holds 1 patent for his invention titled "RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition." This patent provides compositions, formulations, and methods aimed at preventing or reducing the proliferation or migration of retinal cells, as well as addressing epithelial to mesenchymal transition in ocular cells and other tissues.
Career Highlights
Throughout his career, Dhanesh has worked with esteemed institutions such as the Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute, Inc. His experience in these organizations has allowed him to advance his research and contribute to the understanding of ocular diseases.
Collaborations
Dhanesh has collaborated with notable colleagues, including Leo A. Kim and Joseph F. Arboleda-Velasquez. These partnerships have further enriched his research and innovation in the field.
Conclusion
Dhanesh Amarnani's work exemplifies the impact of innovative research in treating ocular conditions. His contributions continue to pave the way for advancements in the field of ophthalmology.